Non-Animal Alternatives Testing Global Market Report 2024


Dublin, March 06, 2024 (GLOBE NEWSWIRE) -- The "Non-Animal Alternatives Testing Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.

The non-animal alternatives testing market size is expected to see rapid growth in the next few years. It will grow to $3.63 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%. The anticipated growth in the forecast period can be ascribed to government initiatives supporting non-animal alternative testing, an increase in research and development activities, and ethical reservations regarding animal experiments, all contributing to market expansion. Key trends expected in this period involve an emphasis on advancing organs-on-chips (OOC) technology, the utilization of in silico trials, the development of advanced 3D bio-printed organs and tissues, the incorporation of model organisms, strategic collaborations and partnerships, and a surge in initiatives and grants aimed at promoting animal-free testing.

The growth of the non-animal testing market is propelled by support from both government and non-governmental organizations. Government entities enforce regulations, enact laws, and allocate funds to endorse non-animal testing methods, including tests on human volunteers and advanced computer-modeling techniques. People for the Ethical Treatment of Animals (PETA) India, for example, demonstrated its commitment to advancing animal-free methods for toxicology testing by announcing a grant of 7 lakh rupees in 2022. Similar initiatives promoting non-animal testing procedures are also undertaken by countries such as Denmark, Brazil, Germany, Switzerland, Australia, China, and Korea. The consistent support from governmental and non-governmental sources plays a pivotal role in driving the growth of the non-animal testing market.

Leading companies in the non-animal alternative testing sector are engaging in collaborations to advance alternatives to animal testing and gain a competitive advantage in the market. These collaborations serve to expedite the adoption of animal-free safety science. For example, in February 2023, Unilever partnered with a global coalition of cosmetics manufacturers, suppliers, industry associations, and animal protection organizations. The objective of this collaboration is to promote innovation in animal-free cosmetics, personal care products, and ingredients. The partnership involves funding and scientific evaluation of new safety assessment approaches, aiming to instill confidence in animal-free safety science.

A selection of companies mentioned in this report includes

  • Evotec SE (Cyprotex)
  • Bio-Rad Laboratories, Inc
  • BioIVT
  • Emulate, Inc
  • MatTek Corporation
  • SGS SA
  • Gentronix Limited
  • Promega Corporation
  • InSphero
  • VITROCELL Systems GmbH
  • Abbott India Limited
  • Becton Dickinson Private Limited
  • Biocartis Group NV
  • Bio-Techne India Private Limited
  • Danaher
  • Cleaver Scientific
  • China Tissue Engineering Co., Ltd. (J-TEC)
  • Reprocell, Inc.
  • Organ Technologies Co. Ltd
  • Mimetas
  • JRF Global
  • PharmaCo-Cell Company Ltd
  • Vessel Inc
  • Modulus Discovery
  • Sanofi
  • F. Hoffmann-La Roche AG
  • Siemens Healthineers AG
  • Qiagen N.V
  • bioMerieux SA
  • QuantuMDx
  • Interlabservis
  • Roche Diagnostics
  • GeneMe
  • TestLine Clinical Diagnostics s.r.o
  • Thermo Fisher Scientific
  • PerkinElmer
  • GE Healthcare
  • Waters Corporation
  • Agilent Technologies
  • Bruker Corporation
  • Oxford Nanopore Technologies
  • 10x Genomics
  • Organovo Holdings
  • EMD Millipore
  • Cyprotex
  • RegeneMed Inc
  • H?REL Corporation
  • Nortis
  • In Silico Biosciences Inc
  • IOMICS Corporation
  • Charles River Laboratories
  • The Jackson Laboratory
  • Envigo
  • Taconic Biosciences, Inc.
  • Cyagen Biosciences
  • Crown Biosciences
  • Harbour BioMed
  • Genewiz
  • Pacific Biosciences
  • Group 42 (G42) Healthcare
  • I-ONE
  • Wadi Jeddah Co
  • Philips
  • King Abdullah International Medical Research Center
  • Parexel
  • Soins Global
  • Pfizer South Africa
  • Dischem Pharmacy
  • Cipla Medpro South Africa Limited
  • Novartis South Africa
  • Synexa Life Sciences
  • IQVIA
  • Oceanic S. A
  • Hean

For more information about this report visit https://www.researchandmarkets.com/r/z6s4pn

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

 

Coordonnées